idw - Informationsdienst
Wissenschaft
06.06.2013 - 07.06.2013 | Düsseldorf
Persons with an increased diabetes risk are often not identified in medical practice, although there is good evidence that the progression of hyperglycaemia to manifest diabetes can be prevented or delayed. Diabetes risk models provide the possibility of risk estimation based on parameters available to the general practitioner. For public-health interventions, risk factor questionnaires and risk scores can be used to stratify populations before inviting those at high risk to undergo further testing. Numerous risk-factor based prediction models for type 2 diabetes have been developed, but the estimation of individual risk and the development of risk scores with relevance for clinical practice and public health remain challenging.
The symposium will present recent developments and will provide the opportunity for a discussion of methods for deriving and validating prediction models, their application in different settings as well as associated barriers and benefits.
On the second day, current knowledge about cost-effectiveness of interventions to prevent and treat diabetes will be presented. Furthermore, methodological challenges to assess effect measures and cost data will be discussed.
Objectives
• To introduce novel developments in the pathophysiology of type 2 diabetes
• To introduce the development, validation and application of prognostic models
• To provide a review of available diabetes risk prediction models
• To introduce risk models for micro- and macrovascular complications
• To discuss the role of novel biomarkers and genes in diabetes prognostic models
• To discuss the benefits, harms and barriers of diabetes prognostic models in routine care
• To discuss challenges to assess effect measures and cost data
The Working Group Epidemiology, Health Care & Economics of the BMBF Competence Network Diabetes mellitus and the German Diabetes Center (DDZ) invites clinicians and research scientists in the fields of type 2 diabetes prevention and chronic disease risk prediction to discuss these issues during a two-day symposium.
Schedule 6.6.2013
9:00 – 17:00h
Prognostic Models in Diabetology
Pathophysiology of type 2 diabetes and its complications: Implications for prognostic models
Prof. Dr. med. Karsten Müssig,
German Diabetes Center, Düsseldorf
Developing, validating and applying prognostic models
Prof. Karel GM Moons, MD, PHD,
Dept. of Epidemiology, University Medical Center, Utrecht, Netherlands
Epidemiology of type 2 diabetes and its complications
Dr. med. Teresa Tamayo, M.A. Soz.,
German Diabetes Center, Düsseldorf
Type 2 diabetes risk scores: update 2013
Prof. Matthias Schulze
German Institute of Human Nutrition (DIfE), Potsdam-Rehbrücke
Risk scores for diabetes complications:
a. Peripheral neuropathy
Brenda Bongaerts, PHD,
German Diabetes Center, Düsseldorf
b. Cardiovascular outcomes
Prof. Wolfgang Koenig, Department of Internal Medicine II
Cardiology, University of Ulm Medical Centre, Ulm
Novel biomarkers and genes in diabetes prognostic models
PD. Dr. Christian Herder,
German Diabetes Center, Düsseldorf
Implementation in routine care: effectiveness, benefit, harms and barriers
Dr. Bernd Kowall,
German Diabetes Center, Düsseldorf
Summary and Outlook
PD Dr. med. Wolfgang Rathmann MSPH,
German Diabetes Center, Düsseldorf
Schedule 7.6.2013
10:00 – 14:00h
Health Services Research and Health Economics – cost and effects in health economic evaluations
Health economic evaluation of diabetes prevention and treatment – can we save costs?
Professor William H Herman PhD MPH,
Michigan Center for Diabetes Translational Research, Michigan, USA
Health utilities for patients with type 2 diabetes – towards German reference values
Prof. Dr. Rolf Holle
Institute of Health Economics and Health Care Management, Helmholtz Zentrum München
Cost for medication and patient time cost in patients by diabetes stage – basis health economic evaluation of German diabetes treatment and prevention
Prof. Dr. Dr. Andrea Icks MBA,
German Diabetes Center, Düsseldorf
Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies
Ina-Maria Rückert, MPH
Institute of Epidemiology II, Helmholtz Zentrum München
Summary and Outlook
Prof. Dr. Dr. Andrea Icks MBA,
German Diabetes Center, Düsseldorf
Hinweise zur Teilnahme:
The symposium is limited to 150 participants. Please register before May 17th.
Termin:
06.06.2013 ab 09:00 - 07.06.2013 14:00
Anmeldeschluss:
17.05.2013
Veranstaltungsort:
Kassenärztliche Vereinigung Nordrhein
Hauptstelle
Tersteegenstraße 9
40474 Düsseldorf
Nordrhein-Westfalen
Deutschland
Zielgruppe:
Wirtschaftsvertreter, Wissenschaftler
E-Mail-Adresse:
Relevanz:
international
Sachgebiete:
Ernährung / Gesundheit / Pflege, Gesellschaft, Medizin
Arten:
Konferenz / Symposion / (Jahres-)Tagung
Eintrag:
11.04.2013
Absender:
Dr. Olaf Spörkel
Abteilung:
Presse- und Öffentlichkeitsarbeit
Veranstaltung ist kostenlos:
ja
Textsprache:
Englisch
URL dieser Veranstaltung: http://idw-online.de/de/event43247
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).